1. Home
  2. CGEM vs LYTS Comparison

CGEM vs LYTS Comparison

Compare CGEM & LYTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEM
  • LYTS
  • Stock Information
  • Founded
  • CGEM 2016
  • LYTS 1976
  • Country
  • CGEM United States
  • LYTS United States
  • Employees
  • CGEM N/A
  • LYTS N/A
  • Industry
  • CGEM Biotechnology: Pharmaceutical Preparations
  • LYTS Building Products
  • Sector
  • CGEM Health Care
  • LYTS Consumer Discretionary
  • Exchange
  • CGEM Nasdaq
  • LYTS Nasdaq
  • Market Cap
  • CGEM 506.1M
  • LYTS 518.5M
  • IPO Year
  • CGEM 2021
  • LYTS N/A
  • Fundamental
  • Price
  • CGEM $7.89
  • LYTS $15.80
  • Analyst Decision
  • CGEM Strong Buy
  • LYTS Strong Buy
  • Analyst Count
  • CGEM 7
  • LYTS 2
  • Target Price
  • CGEM $32.86
  • LYTS $28.00
  • AVG Volume (30 Days)
  • CGEM 520.6K
  • LYTS 164.7K
  • Earning Date
  • CGEM 05-14-2025
  • LYTS 04-24-2025
  • Dividend Yield
  • CGEM N/A
  • LYTS 1.26%
  • EPS Growth
  • CGEM N/A
  • LYTS N/A
  • EPS
  • CGEM N/A
  • LYTS 0.76
  • Revenue
  • CGEM N/A
  • LYTS $523,020,999.00
  • Revenue This Year
  • CGEM N/A
  • LYTS $20.24
  • Revenue Next Year
  • CGEM N/A
  • LYTS $7.64
  • P/E Ratio
  • CGEM N/A
  • LYTS $20.77
  • Revenue Growth
  • CGEM N/A
  • LYTS 10.45
  • 52 Week Low
  • CGEM $6.85
  • LYTS $13.63
  • 52 Week High
  • CGEM $30.19
  • LYTS $25.50
  • Technical
  • Relative Strength Index (RSI)
  • CGEM 47.24
  • LYTS 39.00
  • Support Level
  • CGEM $6.93
  • LYTS $15.57
  • Resistance Level
  • CGEM $8.10
  • LYTS $16.52
  • Average True Range (ATR)
  • CGEM 0.52
  • LYTS 0.90
  • MACD
  • CGEM 0.07
  • LYTS 0.02
  • Stochastic Oscillator
  • CGEM 83.20
  • LYTS 39.34

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

About LYTS LSI Industries Inc.

LSI Industries Inc provides corporate visual image solutions to the petroleum and convenience store industry. The company's operating segments include Lighting and Display Solutions. It generates maximum revenue from the Lighting segment. Lighting Segment manufactures and markets outdoor and indoor lighting and lighting controls for the commercial, industrial, and multi-site retail markets including the petroleum/convenience store, quick-service, and automotive markets. The Display Solutions Segment manufactures, sells and installs exterior and interior visual image and display elements, including printed graphics, structural graphics, digital signage, menu board systems, display fixtures, refrigerated displays and custom display elements.

Share on Social Networks: